Immix Biopharma Target Price

See Immix Biopharma's analyst price targets ($23) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.64

Average Target Price

$23.33

142% upside

3 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-15	Mizuho Securities	$26	169.7% upside
2026-08-11	Morgan Stanley	$19	97.1% upside
2026-08-10	H.C. WainwrightRobert Burns	$25	159.3% upside
2026-05-22	H.C. WainwrightRobert Burns	$20	107.5% upside
2026-03-27	H.C. Wainwright	$15	55.6% upside
2026-02-09	Mizuho SecuritiesGraig Suvannavejh	$14	45.2% upside
2025-12-09	H.C. Wainwright	$12	24.5% upside
2024-07-01	H.C. WainwrightRobert Burns	$7	27.4% downside

Immix Biopharma (IMMX) FAQ

Immix Biopharma posts a target price of $23. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $23 for IMMX means covering analysts, on average, see the stock 142.0% upside of $9.64 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for IMMX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Immix Biopharma's other metric pages and overview cover the third.